Although loss of RB1 function is generally associated with poor prognosis, it simultaneously gives rise to pharmacologically tractable vulnerabilities leading tumor cells to carry lethal levels of DNA damage, CIN, oxidative stress or E2F hyperactivation, causing cell death hopefully at a therapeutically satisfactory degree. This evidence concerns the gene RB1 and neoplasm.